Tempus AI, Inc. (FRA:F3M)

Market Cap	7.65B -21.0%
Revenue (ttm)	1.18B +69.8%
Net Income	-262.71M
EPS	-1.49
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86
Open	42.26
Previous Close	42.52
Day's Range	40.47 - 42.58
52-Week Range	35.79 - 90.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 5, 2026

About Tempus AI

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sc...

• Industry: Medical Laboratories
• Founded: 2015
• Employees: 3,800
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: F3M

Financial Performance

In 2025, Tempus AI's revenue was $1.27 billion, an increase of 83.41% compared to the previous year's $693.40 million. Losses were -$245.03 million, -67.12% less than in 2024.

Financial numbers in USD